{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36533116", "DateRevised": {"Year": "2022", "Month": "12", "Day": "21"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "12", "Day": "05"}], "ELocationID": ["26", "10.1186/s41231-022-00132-6"], "Journal": {"ISSN": "2396-832X", "JournalIssue": {"Volume": "7", "Issue": "1", "PubDate": {"Year": "2022"}}, "Title": "Translational medicine communications", "ISOAbbreviation": "Transl Med Commun"}, "ArticleTitle": "Comments on the optimal use of medical ozone in clinics versus the Ozone High Dose Therapy (OHT) approach.", "Pagination": {"StartPage": "26", "MedlinePgn": "26"}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Scientific Society of Oxygen Ozone Therapy (SIOOT), Gorle, BG Italy."}], "LastName": "Franzini", "ForeName": "Marianno", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Scientific Society of Oxygen Ozone Therapy (SIOOT), Gorle, BG Italy."}], "LastName": "Valdenassi", "ForeName": "Luigi", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Scientific Society of Oxygen Ozone Therapy (SIOOT), Gorle, BG Italy."}], "LastName": "Pandolfi", "ForeName": "Sergio", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.8982.b", "0000 0004 1762 5736"], "Affiliation": "Department of Drug Science, University of Pavia, Pavia, Italy."}], "LastName": "Ricevuti", "ForeName": "Giovanni", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.8982.b", "0000 0004 1762 5736"], "Affiliation": "Department of Drug Science, University of Pavia, Pavia, Italy."}, {"Identifier": [], "Affiliation": "Tirelli Clinical Group, Pordenone, Italy."}], "LastName": "Tirelli", "ForeName": "Umberto", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Scientific Society of Oxygen Ozone Therapy (SIOOT), Gorle, BG Italy."}], "LastName": "Vaiano", "ForeName": "Francesco", "Initials": "F"}, {"Identifier": ["0000-0003-1789-8307"], "AffiliationInfo": [{"Identifier": ["grid.5611.3", "0000 0004 1763 1124"], "Affiliation": "Department of Neurosciences, Biomedicine and Movement Sciences, Unit of Human Anatomy, University of Verona, Strada Le Grazie 8, 37134 Verona, Italy."}], "LastName": "Chirumbolo", "ForeName": "Salvatore", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Transl Med Commun", "NlmUniqueID": "101738095", "ISSNLinking": "2396-832X"}, "CoiStatement": "Competing interestsNone."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "K\u00f6nig B, Lahodny J. Ozone high dose therapy (OHT) improves mitochondrial bioenergetics in peripheral blood mononuclear cells. Transl Med Commun. 2022;7(1):17. doi: 10.1186/s41231-022-00123-7.", "ArticleIdList": ["10.1186/s41231-022-00123-7", "PMC9301618", "35880042"]}, {"Citation": "Chuang GC, Yang Z, Westbrook DG, Pompilius M, Ballinger CA, White CR, et al. Pulmonary ozone exposure induces vascular dysfunction, mitochondrial damage, and atherogenesis. Am J Phys Lung Cell Mol Phys. 2009;297(2):L209\u2013L216.", "ArticleIdList": ["PMC2742788", "19395667"]}, {"Citation": "Bocci V. Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediat Inflamm. 2004;13(1):3\u201311. doi: 10.1080/0962935062000197083.", "ArticleIdList": ["10.1080/0962935062000197083", "PMC1781533", "15203558"]}, {"Citation": "Bocci V, Zanardi I, Travagli V. Oxygen/ozone as a medical gas mixture. A critical evaluation of the various methods clarifies positive and negative aspects. Med Gas Res. 2011;1(1):6. doi: 10.1186/2045-9912-1-6.", "ArticleIdList": ["10.1186/2045-9912-1-6", "PMC3231820", "22146387"]}, {"Citation": "Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009;29(4):646\u2013682. doi: 10.1002/med.20150.", "ArticleIdList": ["10.1002/med.20150", "19260079"]}, {"Citation": "Bocci V. Is it true that ozone is always toxic? The end of a dogma. Toxicol Appl Pharmacol. 2006;216(3):493\u2013504. doi: 10.1016/j.taap.2006.06.009.", "ArticleIdList": ["10.1016/j.taap.2006.06.009", "16890971"]}, {"Citation": "Franzini M, Valdenassi L, Pandolfi S, Tirelli U, Ricevuti G, Simonetti V, et al. The biological activity of medical ozone in the hormetic range and the role of full expertise professionals. Front Public Health. 2022;10:979076. doi: 10.3389/fpubh.2022.979076.", "ArticleIdList": ["10.3389/fpubh.2022.979076", "PMC9523567", "36187636"]}, {"Citation": "Hsu CG, Ch\u00e1vez CL, Zhang C, Sowden M, Yan C, Berk BC. The lipid peroxidation product 4-hydroxynonenal inhibits NLRP3 inflammasome activation and macrophage pyroptosis. Cell Death Differ. 2022;29(9):1790\u20131803. doi: 10.1038/s41418-022-00966-5.", "ArticleIdList": ["10.1038/s41418-022-00966-5", "PMC9433404", "35264781"]}, {"Citation": "Costanzo M, Cisterna B, Vella A, Cestari T, Covi V, Tabaracci G, et al. Low ozone concentrations stimulate cytoskeletal organization, mitochondrial activity and nuclear transcription. Eur J Histochem. 2015;59(2):2515. doi: 10.4081/ejh.2015.2515.", "ArticleIdList": ["10.4081/ejh.2015.2515", "PMC4503975", "26150162"]}, {"Citation": "Bocci V. The potential toxicity of ozone: side effects and contraindications of ozone therapy. Ozone. 2010;24:75\u201384. doi: 10.1007/978-90-481-9234-2_7.", "ArticleIdList": ["10.1007/978-90-481-9234-2_7"]}, {"Citation": "D\u00edaz-Llera S, Gonz\u00e1lez-Hern\u00e1ndez Y, Prieto-Gonz\u00e1lez EA, Azoy A. Genotoxic effect of ozone in human peripheral blood leukocytes. Mutat Res. 2002;517(1\u20132):13\u201320. doi: 10.1016/S1383-5718(02)00022-0.", "ArticleIdList": ["10.1016/S1383-5718(02)00022-0", "12034304"]}, {"Citation": "Menzel DB. Ozone: an overview of its toxicity in man and animals. J Toxicol Environ Health. 1984;13(2\u20133):183\u2013204.", "ArticleIdList": ["6376815"]}, {"Citation": "Chirumbolo S, Valdenassi L, Simonetti V, Bertossi D, Ricevuti G, Franzini M, et al. Insights on the mechanisms of action of ozone in the medical therapy against COVID-19. Int Immunopharmacol. 2021;96:107777. doi: 10.1016/j.intimp.2021.107777.", "ArticleIdList": ["10.1016/j.intimp.2021.107777", "PMC8112288", "34020394"]}, {"Citation": "Chirumbolo S, Simonetti V, Valdenassi L, Pandolfi S, Vaiano F, Franzini M. Editorial - a practical assessment to prevent serious complications in the use of a gaseous mixture of oxygen-ozone injected by needle-mediated infiltration. Eur Rev Med Pharmacol Sci. 2022;26(7):2224\u20132226.", "ArticleIdList": ["35442506"]}, {"Citation": "Cenci A, Macchia I, La Sorsa V, Sbarigia C, Di Donna V, Pietraforte D. Mechanisms of action of ozone therapy in emerging viral diseases: Immunomodulatory effects and therapeutic advantages with reference to SARS-CoV-2. Front Microbiol. 2022;13:871645. doi: 10.3389/fmicb.2022.871645.", "ArticleIdList": ["10.3389/fmicb.2022.871645", "PMC9069003", "35531273"]}, {"Citation": "Chirumbolo S, Franzini M, Simonetti V, Valdenassi L, Ricevuti G, Bertossi D, et al. Oxygen-ozone autohemotherapy against COVID-19 needs to fit highly experienced, customized, and standardized protocols to succeed. J Med Virol. 2021;93(5):2580\u20132582. doi: 10.1002/jmv.26806.", "ArticleIdList": ["10.1002/jmv.26806", "PMC8013854", "33503267"]}, {"Citation": "Chirumbolo S, Varesi A, Franzini M, Valdenassi L, Pandolfi S, Tirelli U, et al. The Mito-Hormetic mechanisms of ozone in the clearance of SARS-CoV2 and in the COVID-19 therapy. Biomedicines. 2022;10(9):2258. doi: 10.3390/biomedicines10092258.", "ArticleIdList": ["10.3390/biomedicines10092258", "PMC9496465", "36140358"]}, {"Citation": "Franzini M, Valdenassi L, Ricevuti G, Chirumbolo S, Depfenhart M, Bertossi D, et al. Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. Int Immunopharmacol. 2020;88:106879. doi: 10.1016/j.intimp.2020.106879.", "ArticleIdList": ["10.1016/j.intimp.2020.106879", "PMC7414302", "32795898"]}, {"Citation": "Izadi M, Cegolon L, Javanbakht M, Sarafzadeh A, Abolghasemi H, Alishiri G, et al. Ozone therapy for the treatment of COVID-19 pneumonia: a scoping review. Int Immunopharmacol. 2021;92:107307. doi: 10.1016/j.intimp.2020.107307.", "ArticleIdList": ["10.1016/j.intimp.2020.107307", "PMC7752030", "33476982"]}, {"Citation": "Du Plessis LH, van der Westhuizen FH, Kotze HF. The effect of blood ozonation on mitochondrial function and apoptosis of peripheral blood mononuclear cells in the presence and absence of antioxidants African. J Biotechnol. 2007;6(15):1763\u20131769."}, {"Citation": "Hill BG, Benavides GA, Lancaster JR, Jr, Ballinger S, Dell'Italia L, Jianhua Z, et al. Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biol Chem. 2012;393(12):1485\u20131512. doi: 10.1515/hsz-2012-0198.", "ArticleIdList": ["10.1515/hsz-2012-0198", "PMC3594552", "23092819"]}, {"Citation": "Chacko BK, Kramer PA, Ravi S, Benavides GA, Mitchell T, Dranka BP, et al. The bioenergetic health index: a new concept in mitochondrial translational research. Clin Sci (Lond) 2014;127(6):367\u2013373. doi: 10.1042/CS20140101.", "ArticleIdList": ["10.1042/CS20140101", "PMC4202728", "24895057"]}, {"Citation": "Ma K, Chen G, Li W, Kepp O, Zhu Y, Chen Q. Mitophagy, mitochondrial homeostasis, and cell fate. Front Cell Dev Biol. 2020;8:467. doi: 10.3389/fcell.2020.00467.", "ArticleIdList": ["10.3389/fcell.2020.00467", "PMC7326955", "32671064"]}, {"Citation": "Tian L, Li N, Li K, Tan Y, Han J, Lin B, et al. Ambient ozone exposure induces ROS related-mitophagy and pyroptosis via NLRP3 inflammasome activation in rat lung cells. Ecotoxicol Environ Saf. 2022;240:113663. doi: 10.1016/j.ecoenv.2022.113663.", "ArticleIdList": ["10.1016/j.ecoenv.2022.113663", "35642860"]}, {"Citation": "Rimini D, Molinari F, Liboni W, Simonetti V, Franzini M. The speed of reinfusion affects the vascular system during ozone major autohemotherapy. Ozone Ther. 2016;1:6477."}, {"Citation": "Bocci VA, Zanardi I, Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J Transl Med. 2011;9:66. doi: 10.1186/1479-5876-9-66.", "ArticleIdList": ["10.1186/1479-5876-9-66", "PMC3125221", "21575276"]}, {"Citation": "Bocci VA. Tropospheric ozone toxicity vs. usefulness of ozone therapy. Arch Med Res. 2007;38(2):265\u2013267. doi: 10.1016/j.arcmed.2006.09.011.", "ArticleIdList": ["10.1016/j.arcmed.2006.09.011", "17227739"]}, {"Citation": "Calabrese EJ. Originator of the hormesis concept: Rudolf Virchow or Hugo Schulz. Hum Exp Toxicol. 2018;37(9):889\u2013890. doi: 10.1177/0960327117751237.", "ArticleIdList": ["10.1177/0960327117751237", "29284298"]}, {"Citation": "Calabrese EJ. Preconditioning is hormesis part I: documentation, dose-response features and mechanistic foundations. Pharmacol Res. 2016;110:242\u2013264. doi: 10.1016/j.phrs.2015.12.021.", "ArticleIdList": ["10.1016/j.phrs.2015.12.021", "26757428"]}, {"Citation": "Calabrese EJ. Preconditioning is hormesis part II: how the conditioning dose mediates protection: dose optimization within temporal and mechanistic frameworks. Pharmacol Res. 2016;110:265\u2013275. doi: 10.1016/j.phrs.2015.12.020.", "ArticleIdList": ["10.1016/j.phrs.2015.12.020", "26748033"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "6"}, {"Year": "2022", "Month": "11", "Day": "29"}, {"Year": "2022", "Month": "12", "Day": "19", "Hour": "4", "Minute": "29"}, {"Year": "2022", "Month": "12", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "20", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "12", "Day": "5"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36533116", "PMC9734312", "10.1186/s41231-022-00132-6", "132"]}}], "PubmedBookArticle": []}